459 related articles for article (PubMed ID: 19679611)
1. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly.
Alvarez JR; Sierra J; Vega M; Adrio B; Martinez-Comendador J; Gude F; Martinez-Cereijo J; Garcia J
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):842-6. PubMed ID: 19679611
[TBL] [Abstract][Full Text] [Related]
2. eComment: Factors related to bioprosthetic valve calcification in the elderly.
Gunay R; Bicer M; Sensoz Y; Demirtas MM
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):846. PubMed ID: 19828657
[No Abstract] [Full Text] [Related]
3. Fate of aortic bioprostheses: An 18-year experience.
Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
[TBL] [Abstract][Full Text] [Related]
4. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
[TBL] [Abstract][Full Text] [Related]
5. The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.
Bavaria JE; Desai ND; Cheung A; Petracek MR; Groh MA; Borger MA; Schaff HV
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):590-7. PubMed ID: 23477687
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and clinical outcomes with the Biocor valve in the aortic position: an 8-year experience.
Bottio T; Rizzoli G; Thiene G; Nesseris G; Casarotto D; Gerosa G
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1616-23. PubMed ID: 15173715
[TBL] [Abstract][Full Text] [Related]
7. The Mosaic porcine bioprosthesis: role of age on clinical performance in aortic position.
Riess FC; Bader R; Cramer E; Hansen L; Schiffelers S; Wallrath J; Wahl G
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1440-8.e1. PubMed ID: 20850804
[TBL] [Abstract][Full Text] [Related]
8. The Sorin freedom stentless pericardial valve: clinical and echocardiographic performance at 10 years.
Milano AD; Dodonov M; Celiento M; Pizzuti M; Golia G; Faggian G; Bortolotti U; Mazzucco A
Int J Artif Organs; 2012 Jul; 35(7):481-8. PubMed ID: 22661113
[TBL] [Abstract][Full Text] [Related]
9. The Italian study on the Mitroflow postoperative results (ISTHMUS): a 20-year, multicentre evaluation of Mitroflow pericardial bioprosthesis.
ISTHMUS Investigators
Eur J Cardiothorac Surg; 2011 Jan; 39(1):18-26; discussion 26. PubMed ID: 20621499
[TBL] [Abstract][Full Text] [Related]
10. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients.
Sénage T; Le Tourneau T; Foucher Y; Pattier S; Cueff C; Michel M; Serfaty JM; Mugniot A; Périgaud C; Carton HF; Al Habash O; Baron O; Roussel JC
Circulation; 2014 Dec; 130(23):2012-20. PubMed ID: 25355912
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of the Medtronic Mosaic porcine bioprosthesis in the aortic position.
Anselmi A; Flécher E; Ruggieri VG; Harmouche M; Langanay T; Corbineau H; Verhoye JP; Leguerrier A
J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1884-91. PubMed ID: 23988288
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction.
Ius F; Schulz J; Roumieh M; Fleissner F; Ismail I; Tudorache I; Warnecke G; Martens A; Shrestha M; Boethig D; Haverich A; Cebotari S
Eur J Cardiothorac Surg; 2017 Aug; 52(2):264-271. PubMed ID: 28838100
[TBL] [Abstract][Full Text] [Related]
13. Short-term follow up with the 3f Enable aortic bioprosthesis: clinical and echocardiographic results.
Concistrè G; Miceli A; Marchi F; Farneti P; Chiaramonti F; Solinas M; Glauber AG
J Heart Valve Dis; 2013 Nov; 22(6):817-23. PubMed ID: 24597403
[TBL] [Abstract][Full Text] [Related]
14. Truly stentless autologous pericardial aortic valve replacement: an alternative to standard aortic valve replacement.
Chan KM; Rahman-Haley S; Mittal TK; Gavino JA; Dreyfus GD
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):276-83. PubMed ID: 20965520
[TBL] [Abstract][Full Text] [Related]
15. Mitroflow LXA structural deterioration following aortic valve replacement: a single-center experience.
Zannis K; Diplaris K; Monin JL; Khelil N; Debauchez M; Dervanian P; Lansac E; Czirom D; Noghin M; Mankoubi L; Amabile N
J Cardiovasc Surg (Torino); 2018 Oct; 59(5):746-752. PubMed ID: 29786406
[TBL] [Abstract][Full Text] [Related]
16. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.
Axtell AL; Chang DC; Melnitchouk S; Jassar AS; Tolis G; Villavicencio MA; Sundt TM; D'Alessandro DA
J Card Surg; 2018 Dec; 33(12):778-786. PubMed ID: 30525247
[TBL] [Abstract][Full Text] [Related]
17. Twenty-year experience with the St. Jude medical Biocor bioprosthesis in the aortic position.
Eichinger WB; Hettich IM; Ruzicka DJ; Holper K; Schricker C; Bleiziffer S; Lange R
Ann Thorac Surg; 2008 Oct; 86(4):1204-10. PubMed ID: 18805161
[TBL] [Abstract][Full Text] [Related]
18. Eight-year results of Freestyle stentless bioprosthesis in the aortic position: a single-center study of 500 patients.
Deleuze PH; Fromes Y; Khoury W; Maribas P; Lemaire S; Bical OM
J Heart Valve Dis; 2006 Mar; 15(2):247-52. PubMed ID: 16607908
[TBL] [Abstract][Full Text] [Related]
19. Mitroflow pericardial bioprosthesis: structured failure at 4.5 years.
Butany J; Feng T; Suri R; Law K; Christakis G
Cardiovasc Pathol; 2012; 21(6):506-10. PubMed ID: 23137773
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic performance of Trifecta: single-center experience of 400 patients.
Modi A; Budra M; Miskolczi S; Velissaris T; Kaarne M; Barlow CW; Livesey SA; Ohri SK; Tsang GM
Asian Cardiovasc Thorac Ann; 2015 Feb; 23(2):140-5. PubMed ID: 24823382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
